RxDoctor Payments Data

Leslie Henry, NP

Family · Greeneville, TNNPI 1780937763

Payments from drug & device makers

$5,231in general payments, 2019–2025

Across 382 payments — averaging $13.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Novo Nordisk$627
  • Otsuka America Pharmaceutical, Inc.$615
  • Lilly USA, LLC$440
  • Pfizer$427
  • Lundbeck LLC$171
  • plus $2K from 28 others

What the payments were for

  • Food & beverage$5,231100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,231 in reported general payments places this provider in the 90th percentile of 6,706 family providers in Tennessee.

See all family providers in Tennessee

Medicare billing

Part B allowed, 2024
$68,263
Medicare patients
124
Services billed
2,912

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide90$109,372
EliquisApixaban88$71,150
OzempicSemaglutide54$65,343
RexultiBrexpiprazole41$62,924
JardianceEmpagliflozin65$58,459
VraylarCariprazine Hcl27$36,409
RybelsusSemaglutide27$28,889
TrulicityDulaglutide12$27,363
Trelegy ElliptaFluticasone/Umeclidin/Vilanter20$17,756
QuliptaAtogepant13$13,903
Nurtec OdtRimegepant Sulfate12$11,618
TradjentaLinagliptin12$10,678
Spiriva RespimatTiotropium Bromide15$8,289
Repatha SyringeEvolocumab11$6,790
FarxigaDapagliflozin Propanediol12$6,554

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$440$136,735102 claims
Novo NordiskOzempic, Rybelsus$627$94,23281 claims
PfizerEliquis, Nurtec Odt, Prempro$427$85,642112 claims
Boehringer IngelheimJardiance, Tradjenta, Spiriva Respimat$124$77,42792 claims
Otsuka America Pharmaceutical, Inc.Rexulti$615$62,92441 claims
AbbVieVraylar, Qulipta$1,181$50,31240 claims
GSKTrelegy Ellipta$62$17,75620 claims
AstraZenecaFarxiga$45$6,55412 claims
Takeda Pharmaceuticals U.S.A., Inc.Vyvanse$162$4,30411 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 6,706 family providers in Tennessee.

Other family in Greeneville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →